CJC-1295 without DAC

CJC-1295 without DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH) designed to stimulate the pituitary gland to increase the secretion of endogenous growth hormone. Unlike CJC-1295 with DAC (Drug Affinity Complex), this version has a shorter half-life, resulting in more transient and pulsatile growth hormone release that more closely resembles the body’s natural secretion patterns.

In scientific research, CJC-1295 without DAC is studied for its effects on growth hormone axis modulation, including potential influences on muscle repair, fat metabolism, sleep regulation, and overall metabolic function. It is often examined in combination studies with other secretagogues to evaluate synergistic effects on growth hormone release and downstream IGF-1 production.

CJC-1295 without DAC is used in laboratory and preclinical settings to better understand endocrine signaling, growth hormone pulsatility, and its role in tissue regeneration and metabolic health.